View Filing Data

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2014	Apr. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	NU SKIN ENTERPRISES INC
Entity Central Index Key	0001021561
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		58,949,802
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	true
Amendment Description	Correct the certain accounting errors with respect to hyper-inflationary adjustments associated with the Company’s Venezuela subsidiary that should have been recorded as charges to Other Income (Expense) rather than as adjustments to Accumulated Other Comprehensive Loss, and income that should have been recorded to Other Income (Expense) for China tax rebates associated with the Company’s China headquarters.
Document Period End Date	Mar. 31, 2014

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 284,580	$ 525,153	$ 325,720	$ 320,025
Current investments	18,703	21,974
Accounts receivable	56,644	68,652
Inventories, net	410,668	339,669
Prepaid expenses and other	150,375	162,886
Total current assets	920,970	1,118,334
Property and equipment, net	411,929	396,042
Goodwill	112,446	112,446
Other intangible assets, net	81,377	83,168
Other assets	115,751	111,072
Total assets	1,642,473	1,821,062
Current liabilities:
Accounts payable	51,276	82,684
Accrued expenses	439,815	626,284
Current portion of long-term debt	88,031	67,824
Total current liabilities	579,122	776,792
Long-term debt	109,882	113,852
Other liabilities	77,910	71,799
Total liabilities	766,914	962,443
Commitments and contingencies (Note 9)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	399,677	397,383
Treasury stock, at cost - 31.7 million and 32.2 million shares	(848,335)	(826,904)
Accumulated other comprehensive loss	(44,864)	(46,228)
Retained earnings	1,368,990	1,334,277
Total stockholders' equity	875,559	858,619
Total liabilities and stockholders' equity	$ 1,642,473	$ 1,821,062

Consolidated Balance Sheets (Unaudited) Parenthetical - $ / shares shares in Millions	Mar. 31, 2014	Dec. 31, 2013
Stockholders' equity:
Common stock - authorized (in shares)	500.0	500.0
Common stock - par value (in dollars per share)	$ 0.001	$ 0.001
Common stock - issued (in shares)	90.6	90.6
Treasury stock, at cost (in shares)	31.6	31.6

Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands, shares in Millions	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Consolidated Statements of Income (Unaudited) [Abstract]
Revenue	$ 671,061	$ 541,305
Cost of sales	106,644	90,045
Gross profit	564,417	451,260
Operating expenses:
Selling expenses	313,101	233,094
General and administrative expenses	150,119	135,507
Total operating expenses	463,220	368,601
Operating income	101,197	82,659
Other income (expense), net	(17,508)	112
Income before provision for income taxes	83,689	82,771
Provision for income taxes	28,835	28,489
Net income	$ 54,854	$ 54,282
Net income per share (Note 2):
Basic (in dollars per share)	$ 0.93	$ 0.93
Diluted (in dollars per share)	$ 0.90	$ 0.90
Weighted-average common shares outstanding (000s):
Basic (in shares)	58,869	58,352
Diluted (in shares)	61,227	60,566

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 54,854	$ 54,282
Other comprehensive income, net of tax:
Foreign currency translation adjustment	1,858	(3,373)
Net unrealized gains on foreign currency cash flow hedges	(257)	986
Reclassification adjustment for realized losses (gains) in current earnings	(237)	(1,163)
Total	1,364	(3,550)
Comprehensive income	$ 56,218	$ 50,732

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 54,854	$ 54,282
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	12,251	7,612
Foreign currency losses (gains)	24,831	(336)
Stock-based compensation	8,682	5,712
Deferred taxes	6,663	2,826
Changes in operating assets and liabilities:
Accounts receivable	11,597	(8,048)
Inventories, net	(76,730)	(15,995)
Prepaid expenses and other	9,533	(9,997)
Other assets	(3,752)	(7,553)
Accounts payable	(30,692)	5,528
Accrued expenses	(176,449)	32,920
Other liabilities	(1,388)	3,435
Net cash provided by (used in) operating activities	(160,600)	70,386
Cash flows from investing activities:
Purchases of property and equipment	(30,538)	(41,239)
Proceeds of investment sales	12,638	4,844
Purchases of investments	(9,556)	0
Net cash used in investing activities	(27,456)	(36,395)
Cash flows from financing activities:
Exercise of employee stock options	(8,375)	(268)
Payment of debt	(5,834)	(7,816)
Payment of cash dividends	(20,141)	(17,514)
Income tax benefit of options exercised	5,610	2,245
Proceeds from debt	20,000	20,000
Repurchases of shares of common stock	(25,002)	(14,615)
Net cash used in financing activities	(33,742)	(17,968)
Effect of exchange rate changes on cash	(18,775)	(10,328)
Net increase/(decrease) in cash and cash equivalents	(240,573)	5,695
Cash and cash equivalents, beginning of period	525,153	320,025
Cash and cash equivalents, end of period	$ 284,580	$ 325,720

THE COMPANY

3 Months Ended

Mar. 31, 2014

THE COMPANY [Abstract]

THE COMPANY

1.	THE COMPANY

Nu Skin Enterprises, Inc. (the "Company") is a leading, global direct selling company that develops and distributes premium-quality, innovative personal care products and nutritional supplements that are sold worldwide under the Nu Skin and Pharmanex brands and a small number of other products and services. Over the last five years, the Company has introduced new Pharmanex nutritional supplements and Nu Skin personal care products un der its ageLOC anti-aging brand. The Company reports revenue from five geographic regions: Greater China, which consists of Mainland China, Hong Kong, Macau and Taiwan; North Asia, which consists of Japan and South Korea; South Asia/Pacific, which consists of Australia, Brunei, French Polynesia, Indonesia, Malaysia, New Caledonia, New Zealand, the Philippines, Singapore, Thailand and Vietnam; Americas, which consists of the United States, Canada and Latin America; and Europe, Middle East and Africa ("EMEA"), which consists of several markets in Europe as well as Israel, Russia and South Africa (the Company's subsidiaries operating in these countries are collectively referred to as the "Subsidiaries").

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial information as of March 31, 2014, and for the three-month periods ended March 31, 2014 and 2013. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013.

NET INCOME PER SHARE

3 Months Ended

Mar. 31, 2014

NET INCOME PER SHARE [Abstract]

NET INCOME PER SHARE

2.	NET INCOME PER SHARE

Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended March 31, 2014 and 2013, other stock options of 2.0 million and 0.3 million, respectively were excluded from the calculation of diluted earnings per share because they were anti-dilutive.

DIVIDENDS PER SHARE

3 Months Ended

Mar. 31, 2014

DIVIDENDS PER SHARE [Abstract]

DIVIDENDS PER SHARE

3.	DIVIDENDS PER SHARE

In March 2014, the Company's board of directors declared a quarterly cash dividend of $0.345 per share. This quarterly cash dividend of $20.1 million was paid on March 26, 2014, to stockholders of record on March 14, 2014. In May 2014, the Company's board of directors declared a quarterly cash dividend of $0.345 per share to be paid June 11, 2014 to stockholders of record on May 23, 2014.

DERIVATIVE FINANCIAL INSTRUMENTS	3 Months Ended
DERIVATIVE FINANCIAL INSTRUMENTS	Mar. 31, 2014
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]
DERIVATIVE FINANCIAL INSTRUMENTS	4. DERIVATIVE FINANCIAL INSTRUMENTS The Company held mark-to-market forward contracts designated as foreign currency cash flow hedges with notional amounts of 2.9 billion Japanese yen and 11.0 million euros ($28.0 million and $15.1 million, respectively) as of March 31, 2014 and 1.1 billion Japanese yen ($11.7 million) and no euros as of March 31, 2013 to hedge forecasted foreign-currency-denominated intercompany transactions. The contracts held as of March 31, 2014 have maturities through February 2015 and accordingly, all unrealized gains and losses on foreign currency cash flow hedges included in accumulated other comprehensive income will be recognized in current earnings over the next 12 months. The pre-tax net gains on foreign currency cash flow hedges reclassified from accumulated other comprehensive income to revenue were $0.4 million and $1.8 million, respectively for the three-month periods ended March 31, 2014 and 2013. The corresponding tax effects of these transactions were recorded in provision for income tax expense. As of March 31, 2014 and December 31, 2013, there were $0.8 million and $1.3 million, respectively, of unrealized gains included in accumulated other comprehensive income related to foreign currency cash flow hedges. The remaining $45.6 million and $47.5 million as of March 31, 2014 and December 31, 2013, respectively, in accumulated other comprehensive income are related to cumulative translation adjustments.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35706170&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

REPURCHASES OF COMMON STOCK

3 Months Ended

Mar. 31, 2014

REPURCHASES OF COMMON STOCK [Abstract]

REPURCHASES OF COMMON STOCK

5.	REPURCHASES OF COMMON STOCK

During the three-month periods ended March 31, 2014 and 2013, the Company repurchased approximately 0.3 million and 0.4 million shares, respectively, of its Class A common stock under its open market repurchase plan for approximately $25.0 million and $14.6 million, respectively. As of March 31, 2014, $369.5 million was available for repurchases under the stock repurchase program.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

SEGMENT INFORMATION

3 Months Ended

Mar. 31, 2014

SEGMENT INFORMATION [Abstract]

SEGMENT INFORMATION

6.	SEGMENT INFORMATION

The Company operates in a single operating segment by selling products through a global network of independent distributors that operates in a seamless manner from market to market, except for its operations in Mainland China. In Mainland China, the Company utilizes sales employees, contractual sales promoters, and independent direct sellers to distribute its products. Contractual sales promoters sell products in similar fashion to the Company's sales employees, but act as independent agents to sell products through its retail stores and website. Independent direct sellers can sell away from the Company's stores in jurisdictions where the Company has obtained a direct sales license to do so. Selling expenses are the Company's largest expense comprised of the commissions paid to its worldwide independent distributors as well as remuneration to its sales force in Mainland China. The Company manages its business primarily by managing its sales force. The Company does not use profitability reports on a regional or divisional basis for making business decisions. However, the Company does report revenue in five geographic regions: Greater China, North Asia, Americas, South Asia/Pacific and EMEA.

Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

	Three Months Ended March 31,
Revenue:	2014		2013

Greater China	$	278,929	$	170,822
North Asia		195,461		185,910
Americas		79,909		75,692
South Asia/Pacific		71,194		66,957
EMEA		45,568		41,924
Total	$	671,061	$	541,305

Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):

	Three Months Ended March 31,
Revenue:	2014		2013

Nu Skin	$	402,111	$	321,440
Pharmanex		267,272		218,351
Other		1,678		1,514
Total	$	671,061	$	541,305

Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):

	Three Months Ended March 31,
Revenue:	2014		2013

Mainland China	$	212,217	$	119,665
South Korea		114,000		81,095
Japan		81,461		104,815
United States		54,822		56,886
Taiwan		35,764		32,126
Hong Kong		30,948		19,031
Malaysia		19,049		18,043

Long-lived assets:	March 31, 2014		December 31, 2013

Mainland China	$	89,967	$	82,726
South Korea		21,660		14,345
Japan		11,261		9,970
United States		274,489		273,388
Taiwan		1,938		1,928
Hong Kong		2,352		2,497
Malaysia		1,327		1,463

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

DEFERRED TAX ASSETS AND LIABILITIES

3 Months Ended

Mar. 31, 2014

DEFERRED TAX ASSETS AND LIABILITIES [Abstract]

DEFERRED TAX ASSETS AND LIABILITIES

7.	DEFERRED TAX ASSETS AND LIABILITIES

The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise's activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. As of March 31, 2014, the Company has netted these deferred tax assets of $58.4 million (restated). The Company nets these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.

The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. Other than earnings the Company intends to reinvest indefinitely, the Company accrues for the U.S. federal, state and foreign income tax applicable to the earnings. Undistributed earnings that the Company has indefinitely reinvested, and for which no federal income taxes in the U.S. have been provided, aggregate to $50 million as of March 31, 2014 and December 31, 2013. In the event that all non-U.S. subsidiaries' undistributed earnings, which the Company has designated as indefinitely reinvested, were remitted to the United States to fund operating and capital plans, regulatory capital requirements parent company financing or cash flow needs, the amount of incremental taxes would be approximately $5.5 million.

UNCERTAIN TAX POSITIONS

3 Months Ended

Mar. 31, 2014

UNCERTAIN TAX POSITIONS [Abstract]

UNCERTAIN TAX POSITIONS

8.	UNCERTAIN TAX POSITIONS

The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company is no longer subject to tax examinations from the United States Internal Revenue Service (the "IRS") for any years for which tax returns have been filed except for 2011. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2008. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process ("CAP"). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in the CAP program for 2014 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is no longer subject to income tax examinations for years before 2007. Along with the IRS examination of 2011, the Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable.

The Company's unrecognized tax benefits relate to multiple foreign and domestic jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation, it is reasonably possible that the Company's gross unrecognized tax benefits, net of foreign currency adjustments, may decrease within the next 12 months by a range of approximately $3 to $4 million.

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Mar. 31, 2014

COMMITMENTS AND CONTINGENCIES [Abstract]

COMMITMENTS AND CONTINGENCIES

9.	COMMITMENTS AND CONTINGENCIES

The Company is subject to governmental regulations pertaining to product formulation, labeling and packaging, product claims and advertising and to the Company's direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company's sales force is not in compliance with existing statutes, laws, rules or regulations could potentially have a material adverse effect on the Company's operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. Although management believes that the Company is in compliance in all material respects with the statutes, laws, rules and regulations of every jurisdiction in which it operates, no assurance can be given that the Company's compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company's financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation and proceedings involving various matters. Except as noted below, in the opinion of the Company's management, based upon advice of its counsel handling such litigation and proceedings, adverse outcomes, if any, will not likely result in a material effect on the Company's consolidated financial condition, results of operations or cash flows.

The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company's reserves, which would impact its reported financial results.

The Company is currently involved in a dispute related to customs assessments by Yokohama Customs on several of the Company's products for the period of October 2006 through September 2009 in connection with post-importation audits, as well as the disputed portion of the Company's import duties from October 2009 to the present, which the Company has or will hold in bond or pay under protest. Additional assessments related to any prior period are barred by applicable statutes of limitations. The aggregate amount of these assessments and disputed duties was approximately 4.2 billion Japanese yen as of March 31, 2014 (approximately $40.3 million), net of any recovery of consumption taxes. The issue in this case is whether a United States entity utilizing a commissionaire agent in Japan to import its products can use the manufacturer's invoice or must use another valuation method, and, if an alternative method must be used, what the allowable deductions would be in determining the proper valuation. Following the Company's review of the assessments and after consulting with the Company's legal and customs advisors, the Company believes that the additional assessments are improper and are not supported by applicable customs laws. The Company filed letters of protest with the applicable Customs authorities, which were rejected. The Company then appealed the matter to the Ministry of Finance in Japan. In the second quarter of 2011, the Ministry of Finance in Japan denied the Company's administrative appeal. The Company disagrees with the Ministry of Finance's administrative decision. The Company is now pursuing the matter in Tokyo District Court, which the Company believes will provide a more independent determination of the matter. In addition, the Company is currently being required to post a bond or make a deposit to secure any additional duties that may be due and payable on these current imports. Because the Company believes that the assessment of higher duties by the customs authorities is an improper application of the regulations, the Company is currently expensing the portion of the duties the Company believes is supported under applicable customs law, and recording the additional deposit or payment as a receivable within long-term assets on its consolidated financial statements. If the Company is unsuccessful in recovering the amounts assessed and paid, the Company will record a non-cash expense for the full amount of the disputed assessments. The Company anticipates that additional disputed duties will be limited going forward as the Company has entered into an arrangement to purchase a majority of the affected products in Japan from a Japanese company that purchases and imports the products from the manufacturers.

In addition, the Company is currently being sued in several purported class action lawsuits and derivative claims relating to negative media and regulatory scrutiny regarding the Company's business in Mainland China and the associated decline in the Company's stock price. These lawsuits, or others filed alleging similar facts, could result in monetary or other penalties that may affect the Company's operating results and financial condition.

Additionally, in April 2014, the Company responded to a stockholder demand from the Trustees of the Laborers' International Union of North America Local 235 Annuity Fund, seeking to inspect certain corporate records pursuant to Delaware General Corporation Law Section 220.

DEBT

3 Months Ended

Mar. 31, 2014

DEBT [Abstract]

DEBT

10.

DEBT

The Company currently has debt pursuant to various credit facilities and other borrowings. The Company's book value for both the individual and consolidated debt included in the table below approximates fair value. The estimated fair value of our debt is based on interest rates available for debt with similar terms and remaining maturities. The Company has classified these instruments as Level 2 in the fair value hierarchy. The following table summarizes the Company's debt arrangements:

Facility or Arrangement	Original Principal Amount		Balance as of March 31, 2014⁽¹⁾		Balance as of December 31, 2013	Interest Rate	Repayment terms

Multi-currency uncommitted shelf facility⁽²⁾:
U.S. dollar denominated:	$40.0 million	$	17.1 million	$	17.1 million	6.2 %	Notes due July 2016 with annual principal payments that began in July 2010.
	$20.0 million	$	8.6 million	$	11.4 million	6.2 %	Notes due January 2017 with annual principal payments that began in January 2011.
Japanese yen denominated:	3.1 billion yen		0.4 billion yen or $4.3 million		0.4 billion yen or $4.1 million	1.7 %	Notes due April 2014 with annual principal payments that began in April 2008.⁽³⁾
	2.3 billion yen		1.3 billion yen or $12.6 million		1.3 billion yen or $12.3 million	2.6 %	Notes due September 2017 with annual principal payments that began in September 2011.
	2.2 billion yen		0.9 billion yen or $9.0 million		1.2 billion yen or $11.8 million	3.3 %	Notes due January 2017 with annual principal payments that began in January 2011.
	8.0 billion yen		8.0 billion yen or $77.3 million		8.0 billion yen or $75.8 million	1.7 %	Notes due May 2022 with annual principal payments that begin in May 2016.

Revolving credit facilities⁽⁴⁾⁽⁵⁾:
2010			$35.0 million		$35.0 million	Variable 30 day: 0.66%	Revolving line of credit.

2013			$34.0 million		$14.0 million	Variable 30 day: 0.5843%	Revolving line of credit.

^{___________________________}

(1)

The current portion of the Company's debt (i.e. becoming due in the next 12 months) includes $10.4 million of the balance of its Japanese yen-denominated debt under the multi-currency uncommitted shelf facility, $8.6 million of the balance on its U.S. dollar denominated debt under the multi-currency uncommitted shelf facility and $69.0 million of the Company's revolving loans.

(2)

On May 6, 2014, the Company entered into a third amendment of the amended and restated note purchase and private shelf agreement (multi-currency), dated as of May 25, 2012, among the Company, Prudential Investment Management, Inc. and certain other purchasers. The amendment modified the restricted payments covenant to allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $50 million for the quarter ending March 31, 2014, $100 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of the agreement.

(3)	On April 30, 2014, the Company paid the notes in full.

(4)	On April 9, 2014, the Company entered into an additional 364 day revolving line of credit with Bank of America, N.A. with a commitment amount of $50 million. The interest rate is equal to 1 month LIBOR plus 95.0 basis points.

(5)

On May 6, 2014, the Company entered into a fifth amendment of the amended and restated credit agreement, dated as of May 25, 2012, among the Company, various financial institutions, and JPMorgan Chase Bank, N.A. as administrative agent. The amendment modified the restricted payments covenant to allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $50 million for the quarter ending March 31, 2014, $100 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of the agreement. The amendment also fixed the applicable interest rate at LIBOR plus 0.75%, increased the commitment fee to 0.25% and extended the term of the agreement from May 9, 2014 to August 8, 2014, with $15 million reductions in the commitment amount on June 30, 2014 and July 31, 2014.

ACCOUNTING PRONOUNCEMENTS

3 Months Ended

Mar. 31, 2014

ACCOUNTING PRONOUNCEMENTS [Abstract]

ACCOUNTING PRONOUNCEMENTS

11.	ACCOUNTING PRONOUNCEMENTS

In July 2013, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the Emerging Issues Task Force). This ASU addresses when unrecognized tax benefits should be presented as reductions to deferred tax assets for net operating loss carryforwards in the financial statements. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of ASU 2013-11 did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.

REVISIONS

3 Months Ended

Mar. 31, 2014

REVISIONS [Abstract]

REVISIONS

12.

REVISIONS

The presentation of the Company's consolidated statements of income for the first quarter of 2013 was revised to reduce the selling expense and revenue by $8.8 million related to an error in the classification of selling rebates. The revision had no effect on the operating income, net income or comprehensive income, the consolidated balance sheet or cash flows. The revision was not considered to be material to the previously issued financial statements.

VENEZUELA HIGHLY INFLATIONARY ACCOUNTING

3 Months Ended

Mar. 31, 2014

VENEZUELA HIGHLY INFLATIONARY ACCOUNTING [Abstract]

VENEZUELA HIGHLY INFLATIONARY ACCOUNTING

13.	VENEZUELA HIGHLY INFLATIONARY ACCOUNTING

The Company commenced operations in Venezuela in 2007, where it markets a variety of personal care and nutritional products. Total assets in Venezuela as of March 31, 2014 are $27.4 million, $24.3 of which are monetary assets. The Venezuela subsidiary also has a $34.8 million intercompany balance to its parent company as of March 31, 2014, with respect to charges for inventory, commissions, license fees and service fees. The Company imports all of its products into Venezuela from the United States. Venezuela represents a very small portion of the Company's overall business with sales for the three months ended March 31, 2014 representing approximately 1% of the Company's overall revenue.

Since November of 2009, Venezuela has been considered a highly inflationary economy. A country is considered to have a highly inflationary economy if it has a cumulative inflation rate of approximately 100% or more over a three-year period as well as other qualitative factors including historic inflation rate trends (increasing and decreasing), the capital intensiveness of the operation and other pertinent economic factors. The functional currency in highly inflationary economies is required to be the functional currency of the entity's parent company (which for our Venezuela subsidiary is the U.S. dollar), and transactions denominated in the local currency are re-measured to the functional currency. The re-measurement of bolivars into U.S. dollars creates foreign currency transaction gains or losses, which should be included in the Company's consolidated statement of income.

The Venezuela subsidiary did not transition to highly inflationary status until the first quarter of 2014 (see "- 15. Restatement"). As a result, the Company continued to account for the Venezuela subsidiary as a bolivar functional currency entity, rather than a U.S. dollar functional currency entity. In the first quarter of 2014, the Company began to account for this subsidiary as highly inflationary, and therefore changed the functional currency of the entity to the U.S. dollar. As a result, for periods prior to 2014, the Company improperly recorded $6 million related to foreign currency remeasurement adjustments caused by changes in the Venezuela exchange rate in accumulated other comprehensive income (equity). The consolidated statement of income for the three-month period ended March 31, 2014, includes an out-of-period adjustment of $6 million to correct this error. The Company has determined not to restate prior period financial statements because the amount of the adjustment is not material to the prior periods or this reporting period.

The current operating environment in Venezuela continues to be challenging, with high inflation in the country, government restrictions on foreign exchange and pricing controls, and the possibility of the government announcing further devaluations to its currency. Currency restrictions enacted by the Venezuelan government have impacted the ability of the Company to exchange foreign currency at the official rate to pay for imported products, license fees, commissions and other service fees. The Company has been unsuccessful in obtaining U.S. dollars at the official exchange rates and under alternative exchange mechanisms described below. As a result, these foreign exchange controls in Venezuela have limited the Company's ability to repatriate earnings and settle the Company's intercompany obligations, which has resulted in the accumulation of bolivar-denominated cash and cash equivalents in Venezuela.

During the quarter ended March 31, 2014, two new foreign exchange mechanisms ("SICAD I" and "SICAD II") became available in Venezuela. Accordingly, there are three legal mechanisms in Venezuela to exchange currency. As of March 31, 2014, the Company determined it would be most appropriate for it to utilize the SICAD I rate, which was approximately 10.7 bolivars per U.S. dollar, as the Company believes this rate better reflects the rate at which they will be able to convert bolivars to U.S. dollars. As a result of the adoption of this rate during the period ended March 31, 2014, the Company recorded a charge of $15 million (restated) in Other Income (Expense) to reflect foreign currency transaction losses on its net monetary assets denominated in bolivar.

- Definition

The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items.

+ References + Details

SUBSEQUENT EVENT	3 Months Ended
SUBSEQUENT EVENT	Mar. 31, 2014
SUBSEQUENT EVENT [Abstract]
SUBSEQUENT EVENT	14. SUBSEQUENT EVENT As of March 31, 2014, the Company was in violation of its restricted payments covenant under its amended and restated credit agreement, dated as of May 25, 2012, among the Company, various financial institutions, and JPMorgan Chase Bank, N.A. as administrative agent, as amended (the "JPMC Agreement") and its amended and restated note purchase and private shelf agreement (multi-currency), dated as of May 25, 2012, among the Company, Prudential Investment Management, Inc. and certain other purchasers, as amended (the "Prudential Agreement"), which restricts the company from making dividend payments or stock repurchases to the extent the aggregate amount of such payments exceed $100 million plus the cumulative cash flow from operations less capital investments since June 30, 2012. Effective May 6, 2014, the Company entered into amendments of the JPMC Agreement and the Prudential Agreement that allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $50 million for the quarter ending March 31, 2014, $100 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of these agreements. The amendment of the JPMC Agreement also fixed the applicable interest rate at LIBOR plus 0.75%, increased the commitment fee to 0.25% and extended the term of the agreement from May 9, 2014 to August 8, 2014, with $15 million reductions in the commitment amount on June 30, 2014 and July 31, 2014.

RESTATEMENT

3 Months Ended

Mar. 31, 2014

RESTATEMENT [Abstract]

RESTATEMENT

15.	RESTATEMENT

The consolidated financial statements as of March 31, 2014 and for the three-month period ended March 31, 2014 have been restated to correct the accounting related to (i) hyper-inflationary adjustments with respect to operations in Venezuela, and (ii) tax rebates related to the Company's new China headquarters. The hyper-inflationary currency translation adjustments should have been recorded as charges to Other Income (Expense) rather than as adjustments to Accumulated Other Comprehensive Loss. The Company also should have recorded income to Other Income (Expense) for the China tax rebates. The restatement makes these corrections by including a $21 million charge to Other Income (Expense) related to the hyper-inflationary accounting error and $7 million of income related to the China tax rebate. All other adjustments relate to the applicable income tax effects of these errors. With respect to the hyper-inflationary correction, $15 million related to the first quarter of 2014, and $6 million related to periods prior to 2014. With respect to the China tax rebates correction, $2 million related to the first quarter of 2014, and $5 million related to periods prior to 2014. The Company does not plan to amend financial statements for periods prior to 2014 as the amounts were determined to be immaterial. These changes, net of tax, negatively impacted net income for the three-month period ended March 31, 2014 by $9 million.

The following tables reconcile the amounts as originally reported in the Company's Original Form 10-Q for the quarter ended March 31, 2014 compared to the amounts as restated in this Form 10-Q/A.

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Income (Unaudited)

For the Three Month Period Ended March 31, 2014

(U.S. dollars in thousands, except per share amounts)

	As Reported			As Restated			Difference

Revenue	$	671,061		$	671,061		$	-

Cost of sales		106,644			106,644			-

Gross profit		564,417			564,417			-

Operating expenses:
Selling expenses		313,101			313,101			-
General and administrative expenses		150,119			150,119			-
Total operating expenses		463,220			463,220			-

Operating income		101,197			101,197			-

Other income (expense), net		(3,604	)		(17,508	)		(13,904	)
Income before provision for income taxes		97,593			83,689			(13,904	)
Provision for income taxes		33,332			28,835			(4,497	)

Net income	$	64,261		$	54,854		$	(9,407	)

Net income per share:
Basic	$	1.09		$	0.93		$	(0.16	)
Diluted	$	1.05		$	0.90		$	(0.15	)

Weighted average common shares outstanding:
Basic		58,869			58,869			-
Diluted		61,227			61,227			-

NU SKIN ENTERPRISES, INC.

Consolidated Balance Sheets (Unaudited)

March 31, 2014

(U.S. dollars in thousands)

	As Reported		As Restated		Difference

ASSETS
Current assets:
Cash and cash equivalents	$	284,580	$	284,580	$	-
Current investments		18,703		18,703		-
Accounts receivable		56,644		56,644		-
Inventories, net		410,668		410,668		-
Prepaid expenses and other		149,523		150,375		852
		920,118		920,970		852

Property and equipment, net		411,929		411,929		-
Goodwill		112,446		112,446		-
Other intangible assets, net		81,377		81,377		-
Other assets		115,751		115,751		-
Total assets	$	1,641,621	$	1,642,473	$	852

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	51,276	$	51,276		-
Accrued expenses		449,434		439,815		(9,619)
Current portion of debt		88,031		88,031		-
		588,741		579,122		(9,619)

Long-term debt		109,882		109,882		-
Other liabilities		79,418		77,910		(1,508)
Total liabilities		778,041		766,914		(11,127)

Stockholders' equity:
Class A common stock		91		91		-
Additional paid-in capital		399,677		399,677		-
Treasury stock, at cost		(848,335)		(848,335)		-
Accumulated other comprehensive loss		(66,250)		(44,864)		21,386
Retained earnings		1,378,397		1,368,990		(9,407)
		863,580		875,559		11,979
Total liabilities and stockholders' equity	$	1,641,621	$	1,642,473	$	852

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Comprehensive Income (Unaudited)

For the Three Month Period Ended March 31, 2014

(U.S. dollars in thousands)

	As Reported		As Restated		Difference

Net Income	$	64,261	$	54,854	$	(9,407)

Other comprehensive income, net of tax:
Foreign currency translation adjustment		(19,528)		1,858		21,386
Net unrealized gains on foreign currency cash flow hedges		(257)		(257)		-
Reclassification adjustment for realized losses (gains) in current earnings		(237)		(237)		-
		(20,022)		1,364		21,386

Comprehensive income	$	44,239	$	56,218	$	11,979

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Cash Flows (Unaudited)

For the Three Month Period Ended March 31, 2014

(U.S. dollars in thousands)

	As Reported			As Restated			Difference

Cash flows from operating activities:
Net income	$	64,261		$	54,854		$	(9,407	)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		12,251			12,251			-
Foreign currency losses (gains)		3,445			24,831			21,386
Stock-based compensation		8,682			8,682			-
Deferred taxes		9,023			6,663			(2,360	)
Changes in operating assets and liabilities:
Accounts receivable		11,597			11,597			-
Inventories, net		(76,730	)		(76,730	)		-
Prepaid expenses and other		9,533			9,533			-
Other assets		(3,752	)		(3,752	)		-
Accounts payable		(30,692	)		(30,692	)		-
Accrued expenses		(166,830	)		(176,449	)		(9,619	)
Other liabilities		(1,388	)		(1,388	)		-

Net cash provided by (used in) operating activities		(160,600	)		(160,600	)		-

Cash flows from investing activities:
Purchases of property and equipment		(30,538	)		(30,538	)		-
Proceeds of investment sales		12,638			12,638			-
Purchases of investments		(9,556	)		(9,556	)		-

Net cash used in investing activities		(27,456	)		(27,456	)		-

Cash flows from financing activities:
Exercise of employee stock options		(8,375	)		(8,375	)		-
Payment of debt		(5,834	)		(5,834	)		-
Payment of cash dividends		(20,141	)		(20,141	)		-
Income tax benefit of options exercised		5,610			5,610			-
Proceeds from debt		20,000			20,000			-
Repurchases of shares of common stock		(25,002	)		(25,002	)		-

Net cash used in financing activities		(33,742	)		(33,742	)		-

Effect of exchange rate changes on cash		(18,775	)		(18,775	)		-

Net increase/(decrease) in cash and cash equivalents		(240,573	)		(240,573	)		-

Cash and cash equivalents, beginning of period		525,153			525,153			-

Cash and cash equivalents, end of period	$	284,580		$	284,580		$	-

SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2014

SEGMENT INFORMATION [Abstract]

Revenue and Long-Lived Assets by Geographic Region

Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

	Three Months Ended March 31,
Revenue:	2014		2013

Greater China	$	278,929	$	170,822
North Asia		195,461		185,910
Americas		79,909		75,692
South Asia/Pacific		71,194		66,957
EMEA		45,568		41,924
Total	$	671,061	$	541,305

Revenue Generated by Each of the Company's Major Product Lines

Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):

	Three Months Ended March 31,
Revenue:	2014		2013

Nu Skin	$	402,111	$	321,440
Pharmanex		267,272		218,351
Other		1,678		1,514
Total	$	671,061	$	541,305

Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):

Revenue and long-lived assets by significant geographic area

	Three Months Ended March 31,
Revenue:	2014		2013

Mainland China	$	212,217	$	119,665
South Korea		114,000		81,095
Japan		81,461		104,815
United States		54,822		56,886
Taiwan		35,764		32,126
Hong Kong		30,948		19,031
Malaysia		19,049		18,043

Long-lived assets:	March 31, 2014		December 31, 2013

Mainland China	$	89,967	$	82,726
South Korea		21,660		14,345
Japan		11,261		9,970
United States		274,489		273,388
Taiwan		1,938		1,928
Hong Kong		2,352		2,497
Malaysia		1,327		1,463

DEBT (Tables)

3 Months Ended

Mar. 31, 2014

DEBT [Abstract]

Summary of Debt Arrangements

Facility or Arrangement	Original Principal Amount		Balance as of March 31, 2014⁽¹⁾		Balance as of December 31, 2013	Interest Rate	Repayment terms

Multi-currency uncommitted shelf facility⁽²⁾:
U.S. dollar denominated:	$40.0 million	$	17.1 million	$	17.1 million	6.2 %	Notes due July 2016 with annual principal payments that began in July 2010.
	$20.0 million	$	8.6 million	$	11.4 million	6.2 %	Notes due January 2017 with annual principal payments that began in January 2011.
Japanese yen denominated:	3.1 billion yen		0.4 billion yen or $4.3 million		0.4 billion yen or $4.1 million	1.7 %	Notes due April 2014 with annual principal payments that began in April 2008.⁽³⁾
	2.3 billion yen		1.3 billion yen or $12.6 million		1.3 billion yen or $12.3 million	2.6 %	Notes due September 2017 with annual principal payments that began in September 2011.
	2.2 billion yen		0.9 billion yen or $9.0 million		1.2 billion yen or $11.8 million	3.3 %	Notes due January 2017 with annual principal payments that began in January 2011.
	8.0 billion yen		8.0 billion yen or $77.3 million		8.0 billion yen or $75.8 million	1.7 %	Notes due May 2022 with annual principal payments that begin in May 2016.

Revolving credit facilities⁽⁴⁾⁽⁵⁾:
2010			$35.0 million		$35.0 million	Variable 30 day: 0.66%	Revolving line of credit.

2013			$34.0 million		$14.0 million	Variable 30 day: 0.5843%	Revolving line of credit.

^{___________________________}

(1)

(2)

(3)	On April 30, 2014, the Company paid the notes in full.

(4)	On April 9, 2014, the Company entered into an additional 364 day revolving line of credit with Bank of America, N.A. with a commitment amount of $50 million. The interest rate is equal to 1 month LIBOR plus 95.0 basis points.

(5)

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 22
-Article 5

+ Details

RESTATEMENT (Tables)

3 Months Ended

Mar. 31, 2014

RESTATEMENT [Abstract]

Restated Consolidated Financial Statements

The following tables reconcile the amounts as originally reported in the Company's Original Form 10-Q for the quarter ended March 31, 2014 compared to the amounts as restated in this Form 10-Q/A.

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Income (Unaudited)

For the Three Month Period Ended March 31, 2014

(U.S. dollars in thousands, except per share amounts)

	As Reported			As Restated			Difference

Revenue	$	671,061		$	671,061		$	-

Cost of sales		106,644			106,644			-

Gross profit		564,417			564,417			-

Operating expenses:
Selling expenses		313,101			313,101			-
General and administrative expenses		150,119			150,119			-
Total operating expenses		463,220			463,220			-

Operating income		101,197			101,197			-

Other income (expense), net		(3,604	)		(17,508	)		(13,904	)
Income before provision for income taxes		97,593			83,689			(13,904	)
Provision for income taxes		33,332			28,835			(4,497	)

Net income	$	64,261		$	54,854		$	(9,407	)

Net income per share:
Basic	$	1.09		$	0.93		$	(0.16	)
Diluted	$	1.05		$	0.90		$	(0.15	)

Weighted average common shares outstanding:
Basic		58,869			58,869			-
Diluted		61,227			61,227			-

NU SKIN ENTERPRISES, INC.

Consolidated Balance Sheets (Unaudited)

March 31, 2014

(U.S. dollars in thousands)

	As Reported		As Restated		Difference

ASSETS
Current assets:
Cash and cash equivalents	$	284,580	$	284,580	$	-
Current investments		18,703		18,703		-
Accounts receivable		56,644		56,644		-
Inventories, net		410,668		410,668		-
Prepaid expenses and other		149,523		150,375		852
		920,118		920,970		852

Property and equipment, net		411,929		411,929		-
Goodwill		112,446		112,446		-
Other intangible assets, net		81,377		81,377		-
Other assets		115,751		115,751		-
Total assets	$	1,641,621	$	1,642,473	$	852

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	51,276	$	51,276		-
Accrued expenses		449,434		439,815		(9,619)
Current portion of debt		88,031		88,031		-
		588,741		579,122		(9,619)

Long-term debt		109,882		109,882		-
Other liabilities		79,418		77,910		(1,508)
Total liabilities		778,041		766,914		(11,127)

Stockholders' equity:
Class A common stock		91		91		-
Additional paid-in capital		399,677		399,677		-
Treasury stock, at cost		(848,335)		(848,335)		-
Accumulated other comprehensive loss		(66,250)		(44,864)		21,386
Retained earnings		1,378,397		1,368,990		(9,407)
		863,580		875,559		11,979
Total liabilities and stockholders' equity	$	1,641,621	$	1,642,473	$	852

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Comprehensive Income (Unaudited)

For the Three Month Period Ended March 31, 2014

(U.S. dollars in thousands)

	As Reported		As Restated		Difference

Net Income	$	64,261	$	54,854	$	(9,407)

Other comprehensive income, net of tax:
Foreign currency translation adjustment		(19,528)		1,858		21,386
Net unrealized gains on foreign currency cash flow hedges		(257)		(257)		-
Reclassification adjustment for realized losses (gains) in current earnings		(237)		(237)		-
		(20,022)		1,364		21,386

Comprehensive income	$	44,239	$	56,218	$	11,979

NU SKIN ENTERPRISES, INC.

Consolidated Statements of Cash Flows (Unaudited)

For the Three Month Period Ended March 31, 2014

(U.S. dollars in thousands)

	As Reported			As Restated			Difference

Cash flows from operating activities:
Net income	$	64,261		$	54,854		$	(9,407	)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		12,251			12,251			-
Foreign currency losses (gains)		3,445			24,831			21,386
Stock-based compensation		8,682			8,682			-
Deferred taxes		9,023			6,663			(2,360	)
Changes in operating assets and liabilities:
Accounts receivable		11,597			11,597			-
Inventories, net		(76,730	)		(76,730	)		-
Prepaid expenses and other		9,533			9,533			-
Other assets		(3,752	)		(3,752	)		-
Accounts payable		(30,692	)		(30,692	)		-
Accrued expenses		(166,830	)		(176,449	)		(9,619	)
Other liabilities		(1,388	)		(1,388	)		-

Net cash provided by (used in) operating activities		(160,600	)		(160,600	)		-

Cash flows from investing activities:
Purchases of property and equipment		(30,538	)		(30,538	)		-
Proceeds of investment sales		12,638			12,638			-
Purchases of investments		(9,556	)		(9,556	)		-

Net cash used in investing activities		(27,456	)		(27,456	)		-

Cash flows from financing activities:
Exercise of employee stock options		(8,375	)		(8,375	)		-
Payment of debt		(5,834	)		(5,834	)		-
Payment of cash dividends		(20,141	)		(20,141	)		-
Income tax benefit of options exercised		5,610			5,610			-
Proceeds from debt		20,000			20,000			-
Repurchases of shares of common stock		(25,002	)		(25,002	)		-

Net cash used in financing activities		(33,742	)		(33,742	)		-

Effect of exchange rate changes on cash		(18,775	)		(18,775	)		-

Net increase/(decrease) in cash and cash equivalents		(240,573	)		(240,573	)		-

Cash and cash equivalents, beginning of period		525,153			525,153			-

Cash and cash equivalents, end of period	$	284,580		$	284,580		$	-

THE COMPANY (Details)	3 Months Ended
THE COMPANY (Details)	Mar. 31, 2014 Region
THE COMPANY [Abstract]
Number of geographic regions	5

NET INCOME PER SHARE (Details) - shares shares in Millions	3 Months Ended
NET INCOME PER SHARE (Details) - shares shares in Millions	Mar. 31, 2014	Mar. 31, 2013
NET INCOME PER SHARE [Abstract]
Other shares excluded from the calculation of diluted earnings per share (in shares)	2.0	0.3

DIVIDENDS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2014	Sep. 30, 2013	Mar. 31, 2013
DIVIDENDS PER SHARE [Abstract]
Date declared	2014-03	2014-05
Cash dividend declared (in dollars per share)	$ 0.345	$ 0.345
Payment of cash dividends	$ 20,141		$ 17,514
Date paid	Mar. 26, 2014	Jun. 11, 2014
Date of record	Mar. 14, 2014	May 23, 2014

DERIVATIVE FINANCIAL INSTRUMENTS (Details) $ in Thousands, € in Millions, ¥ in Billions	3 Months Ended
	Mar. 31, 2014 USD ($)	Mar. 31, 2013 USD ($)	Mar. 31, 2014 JPY (¥)	Mar. 31, 2014 EUR (€)	Dec. 31, 2013 USD ($)	Mar. 31, 2013 JPY (¥)	Mar. 31, 2013 EUR (€)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Revenue	$ 671,061	$ 541,305
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(44,864)				$ (46,228)
Accumulated Unrealized Gains (Losses) on Foreign Currency Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	800				1,300
Accumulated Unrealized Gains (Losses) on Foreign Currency Cash Flow Hedges [Member] \| Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Revenue	400	1,800
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss)	(45,600)				$ (47,500)
Forward Contracts [Member] \| Cash Flow Hedging [Member] \| Japanese Yen [Member]
Derivative [Line Items]
Notional amount	28,000	$ 11,700	¥ 2.9			¥ 1.1
Forward Contracts [Member] \| Cash Flow Hedging [Member] \| Euros [Member]
Derivative [Line Items]
Notional amount	$ 15,100			€ 11.0			€ 0.0

REPURCHASES OF COMMON STOCK (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Equity, Class of Treasury Stock [Line Items]
Common stock repurchased (in shares)	0.3	0.4
Common stock repurchased	$ 25,000	$ 14,600
Available for repurchase under the repurchase program	$ 369,500

SEGMENT INFORMATION (Details) $ in Thousands	3 Months Ended
SEGMENT INFORMATION (Details) $ in Thousands	Mar. 31, 2014 USD ($) Region ProductLine	Mar. 31, 2013 USD ($)	Sep. 30, 2012 USD ($)	Dec. 31, 2013 USD ($)
SEGMENT INFORMATION [Abstract]
Number of geographic regions \| Region	5
Number of product lines \| ProductLine	3
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 671,061	$ 541,305
North Asia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	195,461	185,910
Greater China [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	278,929	170,822
Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	79,909	75,692
South Asia/Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	71,194	66,957
EMEA [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	45,568	41,924
Japan [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	114,000	81,095
Long-lived assets	21,660			$ 14,345
South Korea [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	81,461	104,815
Long-lived assets	11,261			9,970
Hong Kong [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		30,948	$ 19,031
Long-lived assets	2,352			2,497
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	54,822	56,886
Long-lived assets	274,489			273,388
Mainland China [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	212,217	119,665
Long-lived assets	89,967			82,726
Taiwan [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		35,764	32,126
Long-lived assets	1,938			1,928
Malaysia [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		$ 19,049	$ 18,043
Long-lived assets	$ 1,327			$ 1,463

SEGMENT INFORMATION, Products and Services (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue from External Customer [Line Items]
Revenue	$ 671,061	$ 541,305
Nu Skin [Member]
Revenue from External Customer [Line Items]
Revenue	402,111	321,440
Pharmanex [Member]
Revenue from External Customer [Line Items]
Revenue	267,272	218,351
Other Product Lines [Member]
Revenue from External Customer [Line Items]
Revenue	$ 1,678	$ 1,514

DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($) $ in Millions	Mar. 31, 2014	Dec. 31, 2013
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]
Net deferred tax assets	$ 58.4
Accumulated reinvested foreign earnings	50.0	$ 50.0
Incremental taxes on indefinitely reinvested foreign earnings	$ 5.5

UNCERTAIN TAX POSITIONS (Details) $ in Millions	Mar. 31, 2014 USD ($)
UNCERTAIN TAX POSITIONS [Abstract]
Estimate of change in gross unrecognized tax benefits, net of foreign currency adjustments, within the next 12 months - minimum	$ 3
Estimate of change in gross unrecognized tax benefits, net of foreign currency adjustments, within the next 12 months - maximum	$ 4

COMMITMENTS AND CONTINGENCIES (Details) - Mar. 31, 2014 $ in Millions, ¥ in Billions	USD ($)	JPY (¥)
Loss Contingencies [Line Items]
Aggregate amount of assessments and disputed duties	$ 40.3	¥ 4.2

DEBT (Details)
$ in Thousands, ¥ in Billions

3 Months Ended

May 06, 2014

USD ($)

Apr. 09, 2014

USD ($)

Mar. 31, 2014

USD ($)

Jul. 31, 2014

USD ($)

Jun. 30, 2014

USD ($)

Mar. 31, 2014

JPY (¥)

Feb. 05, 2014

USD ($)

Dec. 31, 2013

USD ($)

Dec. 31, 2013

JPY (¥)

Feb. 05, 2013

USD ($)

REVISIONS (Details) - USD ($) $ in Thousands	3 Months Ended
REVISIONS (Details) - USD ($) $ in Thousands	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenue	$ 671,061	$ 541,305
Selling expenses	313,101	233,094
Operating income	101,197	82,659
Net income	54,854	54,282
Comprehensive income	56,218	50,732
Total assets	1,642,473		$ 1,821,062
Total liabilities and stockholders' equity	1,642,473		$ 1,821,062
Net increase/(decrease) in cash and cash equivalents	(240,573)	$ 5,695
Error in Classification of Selling Rebates [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Revenue	8,800
Selling expenses	8,800
Operating income	0
Net income	0
Comprehensive income	0
Total assets	0
Total liabilities and stockholders' equity	0
Net increase/(decrease) in cash and cash equivalents	$ 0

VENEZUELA HIGHLY INFLATIONARY ACCOUNTING (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2014 USD ($) Bs. / $ Mechanism	Dec. 31, 2013 USD ($)	Mar. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Total assets	$ 1,642,473	$ 1,821,062
Monetary assets	284,580	525,153	$ 325,720	$ 320,025
Restatement Adjustment [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Total assets	852
Monetary assets	$ 0	$ 0
Venezuela [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Number of foreign exchange mechanisms \| Mechanism	2
Number of legal mechanisms \| Mechanism	3
Venezuela [Member] \| SICAD I [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Foreign currency exchange rate \| Bs. / $	10.7
Subsidiary in Venezuela [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Total assets	$ 27,400
Monetary assets	24,300
Payable to parent company	$ 34,800
Subsidiary in Venezuela [Member] \| Maximum [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Percentage of revenue from subsidiary (in hundredths)	1.00%
Other Income (Expense), Net [Member] \| Subsidiary in Venezuela [Member] \| SICAD I [Member] \| Restatement Adjustment [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Translation of monetary assets and liabilities	$ 14,700
Correct Certain Accounting Errors for Hyper-Inflationary Adjustments with Respect to Operations in Venezuela [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Adjustment to accumulated other comprehensive income (equity)	6,200
Out-of-period adjustment to income statement	$ 6,200
Correct Certain Accounting Errors for Hyper-Inflationary Adjustments with Respect to Operations in Venezuela [Member] \| Minimum [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Cumulative inflation rate (n hundredths)	100.00%
Period used to determine highly inflationary economy	3 years

SUBSEQUENT EVENT (Details) - Subsequent Event [Member] - Multi-currency uncommitted shelf facility [Member] - USD ($) $ in Millions	May 06, 2014	Mar. 31, 2014
Subsequent Event [Line Items]
Restricted payments covenant threshold for making dividend payments or stock repurchases		$ 100.0
Interest rate (in hundredths)	0.75%
Commitment fee (in hundredths)	0.25%
Reduction in commitment amount		$ 15.0
Quarter Ending March 31 2014 [Member]
Subsequent Event [Line Items]
Restricted payments covenant threshold for making dividend payments or stock repurchases	$ 50.0
Quarter Ending June 30, 2014 [Member]
Subsequent Event [Line Items]
Restricted payments covenant threshold for making dividend payments or stock repurchases	100.0
Quarter Ending September 30, 2014 [Member]
Subsequent Event [Line Items]
Restricted payments covenant threshold for making dividend payments or stock repurchases	$ 50.0